CH644453A5 - Methode de detection du cancer. - Google Patents

Methode de detection du cancer. Download PDF

Info

Publication number
CH644453A5
CH644453A5 CH277880A CH277880A CH644453A5 CH 644453 A5 CH644453 A5 CH 644453A5 CH 277880 A CH277880 A CH 277880A CH 277880 A CH277880 A CH 277880A CH 644453 A5 CH644453 A5 CH 644453A5
Authority
CH
Switzerland
Prior art keywords
dna
concentration
protein
cancer
bleomycin
Prior art date
Application number
CH277880A
Other languages
English (en)
French (fr)
Inventor
Stanley T Crooke
Louis Galvan
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of CH644453A5 publication Critical patent/CH644453A5/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
CH277880A 1979-04-10 1980-04-10 Methode de detection du cancer. CH644453A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10

Publications (1)

Publication Number Publication Date
CH644453A5 true CH644453A5 (fr) 1984-07-31

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
CH277880A CH644453A5 (fr) 1979-04-10 1980-04-10 Methode de detection du cancer.

Country Status (24)

Country Link
JP (1) JPS55143441A (sv)
KR (1) KR830002502A (sv)
AR (1) AR222700A1 (sv)
AT (1) AT365343B (sv)
AU (1) AU536522B2 (sv)
BE (1) BE882669A (sv)
CH (1) CH644453A5 (sv)
DE (1) DE3013837A1 (sv)
DK (1) DK149980A (sv)
ES (1) ES8103380A1 (sv)
FI (1) FI801078A (sv)
FR (1) FR2454099A1 (sv)
GB (1) GB2047712B (sv)
GR (1) GR67692B (sv)
HU (1) HU183122B (sv)
IE (1) IE49981B1 (sv)
IL (1) IL59772A (sv)
IT (1) IT1143135B (sv)
LU (1) LU82345A1 (sv)
NL (1) NL8002094A (sv)
NO (1) NO801018L (sv)
PH (1) PH15637A (sv)
SE (1) SE8002602L (sv)
ZA (1) ZA802141B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
GB2047712B (en) 1983-02-23
GB2047712A (en) 1980-12-03
NL8002094A (nl) 1980-10-14
ES490396A0 (es) 1981-02-16
AR222700A1 (es) 1981-06-15
IL59772A0 (en) 1980-06-30
KR830002502A (ko) 1983-05-30
FI801078A (fi) 1980-10-11
IE800693L (en) 1980-10-10
FR2454099B1 (sv) 1984-01-27
IT8048370A0 (it) 1980-04-09
IT1143135B (it) 1986-10-22
IE49981B1 (en) 1986-01-22
LU82345A1 (fr) 1980-12-16
AU5719380A (en) 1980-10-16
AT365343B (de) 1982-01-11
IL59772A (en) 1983-05-15
PH15637A (en) 1983-03-11
JPS55143441A (en) 1980-11-08
FR2454099A1 (fr) 1980-11-07
NO801018L (no) 1980-10-13
ZA802141B (en) 1981-04-29
AU536522B2 (en) 1984-05-10
ATA195780A (de) 1981-05-15
HU183122B (en) 1984-04-28
SE8002602L (sv) 1980-12-09
DK149980A (da) 1980-10-11
GR67692B (sv) 1981-09-07
DE3013837A1 (de) 1980-10-30
ES8103380A1 (es) 1981-02-16
BE882669A (fr) 1980-10-06

Similar Documents

Publication Publication Date Title
Spivak et al. Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity diiorder
EP2146209B1 (en) Neurodegenerative markers for Alzheimer's disease
Baldini et al. Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome?
US20110201518A1 (en) Healthy kidney biomarkers
KR20090108006A (ko) 혈장-유래된 미세입자로부터 바이오마커를 확인 및 분석하는 방법
CA2088050A1 (en) Cell necrosis detection through assays for spectrum and breakdown products thereof
WO2013087929A2 (de) Verfahren zur identifizierung von markersequenzen für gynäkologisches malignom
US4270924A (en) Diagnostic method for detecting cancer
Schwartz et al. Quantitative assay of erythrocyte “free” and zinc-protoporphyrin: Clinical and genetic studies
Greney et al. Characterization of imidazoline binding protein (s) solubilized from human brainstem: studies with [3H] idazoxan and [3H] clonidine
CH644453A5 (fr) Methode de detection du cancer.
Bąchor et al. Identyfication of tryptic podocin peptide in the feline urine sediments using LC-MS/MRM method
Bootorabi et al. Modification of carbonic anhydrase II with acetaldehyde, the first metabolite of ethanol, leads to decreased enzyme activity
JP2002539430A (ja) 診断テスト
Deby-Dupont et al. Equine neutrophil myeloperoxidase in plasma: design of a radio-immunoassay and first results in septic pathologies
Tulley et al. Method for the simultaneous determination of cadmium and zinc in whole blood by atomic absorption spectrophotometry and measurement in normotensive and hypertensive humans
KR102475926B1 (ko) 전신 홍반성 루푸스 진단용 바이오마커 조성물 및 이를 이용한 전신 홍반성 루푸스 진단에 필요한 정보를 제공하는 방법
WO2023143650A1 (en) Method for determination of mutated form of mucin-1 protein in a biological sample
EP2855425A2 (en) Novel phenyl glyoxal probes
AU697842B2 (en) A method of determining the degree of aggregation of the betaA4 peptide
WO2024135740A1 (ja) 猫の腎機能障害の検査方法
KR20180117918A (ko) Mfap5 측정 제제를 포함하는 대장암 진단용 조성물, 키트, 및 이를 이용한 대장암 진단 방법
Miura Application of fluorescence polarization to the determination of urinary lysozyme activity
US5804368A (en) Method for screening for prostate cancer by measuring apolipoprotein D levels in body fluid
JP2573189B2 (ja) カリクレインの検出方法

Legal Events

Date Code Title Description
PL Patent ceased